BRUSA, GIANLUCA

BRUSA, GIANLUCA  

DIP. CLINICO SCIENZE RADIOLOGICHE E ISTOCITOPATOLOGICHE  

BRUSA G.L.; G. BRUSA; BRUSA G  

Mostra records
Risultati 1 - 19 di 19 (tempo di esecuzione: 0.083 secondi).
Titolo Autore(i) Anno Periodico Editore Tipo File
Acetylation of FOXO3a transcription factor in response to imatinib of chronic myeloid leukemia Corrado P; Mancini M; Brusa G; Petta S; Martinelli G; Barbieri E; Santucci MA 2009-01-01 LEUKEMIA - 1.01 Articolo in rivista -
Apoptotic death of Bcr-Abl-expressing myeloid progenitors in response to the m-Tor inhibitor RAD001 (Everolimus) is promoted by the nuclear import of c-Abl Mancini M.; Zuffa E.; Corrado P.; Brusa G.; Petta S.; Pagnotta E.; Santucci M.A. 2006-01-01 - s.n 4.02 Riassunto (Abstract) -
CHK2 drives late G1/early S phase arrest of clonal myeloid progenitors expressing the p210 BCR-ABL tyrosine kinase in response to STI571 MAZZACURATI L; PATTACINI L; BRUSA G; MANCINI M; BENVENUTI M; BARBIERI E; MARTINELLI G.; BACCARANI... M; GREENBERGER JS; SANTUCCI MA 2004-01-01 HEMATOLOGY JOURNAL - 1.01 Articolo in rivista -
COVALENT MODIFICATIONS OF HISTONE H4 NH2-TERMINAL TAILS ASSOCIATED WITH P210 BCR-ABL TYROSINE KINASE Brusa G.; Parisi D.; Calonghi N.; Calabrò A.; Mancini M.; Zuffa E.; Arcangeli E.; Santucci M.A. 2004-01-01 - Mario Cazzola 4.01 Contributo in Atti di convegno -
Cyclin-dependent kinase 2 (Cdk2) activity at the G1 to S boundary has a role in the resistance of Chronic Myeloid Leukemia (CML) haematopoietic progenitors to the tyrosine kinase inhibitor STI571 (Imatinib) M. Mancini; G. Brusa; A. Calabrò; N. Calonghi; E. Pagnotta; M. Alessandra Santucci; L. Masotti 2004-01-01 - Graphital 4.01 Contributo in Atti di convegno -
Endoplasmic reticulum stress initiates apoptotic death induced by STI571 inhibition of p210 bcr-abl tyrosine kinase. PATTACINI L; MANCINI M; MAZZACURATI L; BRUSA G; BENVENUTI M; MARTINELLI G.; BACCARANI M; SANTUCCI... MA. 2004-01-01 LEUKEMIA RESEARCH - 1.01 Articolo in rivista -
Genomic imbalances associated with secondary acute leukemias in Hodgkin lymphoma. Brusa G; Zuffa E; Hattinger CM; Serra M; Remondini D; Castellani G; Righi S; Campidelli C; Pileri... S; Zinzani PL; Gabriele A; Mancini M; Corrado P; Barbieri E; Santucci MA. 2007-01-01 ONCOLOGY REPORTS - 1.01 Articolo in rivista -
Genomic instability in the development of non-Hodgkin lymphomas secondary to Hodgkin lymphoma Brusa G.; Zuffa E.; Remondini D.; Castellani G.; Serra M.; Hattinger C.M.; Morandi L.; Zinzani P....L.; Mancini M.; Corrado P.; Barbieri E.; Santucci M.A. 2007-01-01 - s.n 4.02 Riassunto (Abstract) -
GENOMIC UNBALANCES ASSOCIATED WITH THE RESISTANCE TO IONIZING RADIATIONS OF A HUMAN OSTEOSARCOMA CELL LINE (SAOS) DETECTED BY COMPARATIVE GENOMIC HYBRIDIZATION (CGH-BASED TECHNIQUE) Brusa G.; Hattinger C.; Serra M.; Astolfi A.; Saponaro M.; Cammelli S.; Santucci M.A.; Barbieri E. 2004-01-01 - Mario Cazzola 4.01 Contributo in Atti di convegno -
HDAC1 (histone deacetylase1) involvement in Chronic Myeloid Leukemia Brusa G.; Mancini M.; Zuffa E.; Santucci M.A. 2005-01-01 - s.n 4.01 Contributo in Atti di convegno -
IPO-trimethylation of histone H3-lysine9 associated with P210 BCR-ABL tyrosine kinase of chronic myeloid leukaemia Mancini M; Zuffa E; Veljkovic N; Brusa G; Corrado P; Corradi V; Martinelli G; Barbieri E; Santucc...i MA. 2008-01-01 BRITISH JOURNAL OF HAEMATOLOGY - 1.01 Articolo in rivista -
Modulation of apoptotic signalling by 9-hydroxystearic acid in osteosarcoma cells Calonghi N; Pagnotta E; Parolin C; Molinari C; Boga C; Dal Piaz F; Brusa GL; Santucci MA; Masotti L. 2007-01-01 BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS - 1.01 Articolo in rivista -
NEW STRATEGIES IN THE TREATMENT OF CHRONIC MYELOID LEUKEMIA. COMBINED USE OF SRC AND TYROSINE KINASE INHIBITORS CIRCUMVENTS THE DEVELOPMENT OF DRUG-RESISTANCE M. Mancini; G. Brusa; E. Zuffa; T. Graffone; F. Pennisi; N. Calonghi; L. Masotti; M. A. Santucci 2005-01-01 - Tipografia Senese 4.01 Contributo in Atti di convegno -
P210 Bcr-abl tyrosine kinase interaction with histone deacetylase 1 modifies histone H4 acetylation and chromatin structure of chronic myeloid leukaemia haematopoietic progenitors Brusa G; Zuffa E; Mancini M; Benvenuti M; Calonghi N; Barbieri E; Santucci MA. 2006-01-01 BRITISH JOURNAL OF HAEMATOLOGY - 1.01 Articolo in rivista -
P210 BCR-ABL tyrosine kinase prevents apoptotic cell death through multiple pathways converging at mitochondrial membranes M. Mancini; N. Calonghi; E. Pagnotta; L. Masotti; G. Brusa; E. Zuffa; A. Calabrò; E. Barbieri; M.... A. Santucci 2005-01-01 GENE THERAPY & MOLECULAR BIOLOGY - 1.01 Articolo in rivista -
Persistent Cdk2 inactivation drives growth arrest of BCR-ABL-expressing cells in response to dual inhibitor of SRC and ABL kinases SKI606 Mancini M; Brusa G; Zuffa E; Corrado P; Martinelli G; Grafone T; Barbieri E; Santucci MA 2007-01-01 LEUKEMIA RESEARCH - 1.01 Articolo in rivista -
Post-translational modifications of FOXO3a transcription factor associated with the constitutive tyrosine kinase activity of p210 BCR-ABL protein. Implications for new targeted therapies Corrado P.; Brusa G.; Mancini M.; Zuffa E.; Corradi V.; Martinelli G.; Barbieri E.; Santucci M.A. 2007-01-01 - s.n 4.02 Riassunto (Abstract) -
The m-TOR inhibitor everolimus complements pro-apoptotic and anti-proliferative effects of imatinib on chronic myeloid leukemia progenitors by promoting the nuclear import of normal c-Abl protein Mancini M.; Zuffa E.; Corrado P.; Pagnotta E.; Brusa G.; Corradi V.; martinelli G.; Barbieri E.; ...Santucci M.A. 2007-01-01 - s.n 4.02 Riassunto (Abstract) -
The p210BCR-ABL tyrosine kinase of chronic myeloid leukemia causes resistance to radio-induced apoptotic death by inhibiting the proapoptotic BAX gene MANCINI M; BRUSA G; BENVENUTI M; MAZZACURATI L; CAMPANINI F; BARBIERI E; CAMMELLI S; CALONGHI N; ...MARTINELLI G; BACCARANI M.; SANTUCCI MA 2004-01-01 LEUKEMIA - 1.01 Articolo in rivista -